Definitely need more of these updates to keep shareholders informed. I’m surprised with these backlogs that their instruments aren’t being used more pathology labs which saves much more time and hence labour costs. To be able to differentiate between COVID strains also a big plus as again, labs don’t have to determine which is which. I tested positive today and yet still unsure which one I caught ?? and don’t really know how to get the answer
News: GSS Genetic Signatures Expects Sales Of At Least A$21M For Half Year, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.36M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 34.5¢ | $93.63K | 271.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 4501 | 1 |
View Market Depth
| Last trade - 15.03pm 25/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |